The 4th annual Mobile in Clinical Trials is full-day conference preceding DPharm: Disruptive Innovations to Advance Clinical Trials and goes into detail on:
- Real-time implementation of mobile solutions
- trials driving efficiency
- How to scale up
- Perceived barriers and how to overcome them
- Moving past the hype of mhealth and producing evidence
- Optimizing the true value of mobile data
- Mobile 2.0, wearable, sensors, apps and mobile devices
Morning Sessions
Program chair Dr Dan Karlin, Pfizer, presents the opening remarks for the event. The morning includes sessions on: how to overcome the cultural barriers to implementing mobile technology; CTTI's findings on their mobile clinical trials program and recommendations on novel endpoints; case study learnings from Medidata; FDA guidance on implementing digital/mobile strategies and tools in clinical research; GSK's PARADE study; Roche's Parkinson's disease study; and new technologies in live five-minute demonstrations.
Afternoon Sessions
The afternoon sessions cover: how to introduce digital tools in a clinical trial from start to finish; demonstrating value-added to a Phase IV trial by introducing a valid wearable; the current realities of the virtual trial model; Verily's study watch tackling the scalability of wearables in clinical trials; the why, what, where and how of the digital coach in clinical trials; and a call to action and reflection on the the day's learnings.
New for 2017 is the optional pre-DPharm workshop on September 6, following the full-day Mobile in Clinical Trials @DPharm meeting. "Trial Innovation Co-Design Workshop: Help Create Solutions to Assist Clinical Research Participants," led by Eli Lilly and Company's Barry Crist and Dave Crumbacher, gives attendees the chance to be an innovator. Using co-design and human-centered approaches, you will work with a small team to brainstorm and design an innovation to assist participants in Clinical Trials.
- Real-time implementation of mobile solutions
- trials driving efficiency
- How to scale up
- Perceived barriers and how to overcome them
- Moving past the hype of mhealth and producing evidence
- Optimizing the true value of mobile data
- Mobile 2.0, wearable, sensors, apps and mobile devices
Morning Sessions
Program chair Dr Dan Karlin, Pfizer, presents the opening remarks for the event. The morning includes sessions on: how to overcome the cultural barriers to implementing mobile technology; CTTI's findings on their mobile clinical trials program and recommendations on novel endpoints; case study learnings from Medidata; FDA guidance on implementing digital/mobile strategies and tools in clinical research; GSK's PARADE study; Roche's Parkinson's disease study; and new technologies in live five-minute demonstrations.
Afternoon Sessions
The afternoon sessions cover: how to introduce digital tools in a clinical trial from start to finish; demonstrating value-added to a Phase IV trial by introducing a valid wearable; the current realities of the virtual trial model; Verily's study watch tackling the scalability of wearables in clinical trials; the why, what, where and how of the digital coach in clinical trials; and a call to action and reflection on the the day's learnings.
New for 2017 is the optional pre-DPharm workshop on September 6, following the full-day Mobile in Clinical Trials @DPharm meeting. "Trial Innovation Co-Design Workshop: Help Create Solutions to Assist Clinical Research Participants," led by Eli Lilly and Company's Barry Crist and Dave Crumbacher, gives attendees the chance to be an innovator. Using co-design and human-centered approaches, you will work with a small team to brainstorm and design an innovation to assist participants in Clinical Trials.
